|

Anti-STEAP1 CAR T-cells Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Anti-STEAP1 CAR T Cells, Anti-STEAP1 CAR-T Cells, STEAP1 CAR-T Cells, STEAP1-targeting CAR T-cells

Pipeline

Phase 1/2: 1

Top Sponsors

  • Fred Hutchinson Cancer Center1

Indications

  • Castration-Resistant Prostate Carcinoma1
  • Stage IVB Prostate Cancer AJCC v81
  • Metastatic Prostate Adenocarcinoma1
  • Cancer1

Seattle, Washington1 trial

Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer

Fred Hutch/University of Washington Cancer Consortium

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.